Cambio - Excellence in Molecular Biology

CRISPR-Cas 9

CRISPR-Cas 9: Reagents for CRISPR-Cas9

Reagents and kits used in CRISPR/Cas 9

Plasmid-Safe™ ATP-Dependent DNase

Plasmid-Safe™ ATP-Dependent DNase provides researchers with a fast, easy, and powerful method to selectively remove contaminating bacterial chromosomal DNA remaining in preparations of plasmid, fosmid, cosmid, and BAC clones

BioSearch Tech (Lucigen/Epicentre)

Catalogue No.DescriptionPack SizePriceQty
E3101KPlasmidSafe™ ATP-Dependent DNase10U/µl 1,000U £103.00 Quantity Add to Order
E3110KPlasmidSafe™ ATP-Dependent DNase10U/µl 10,000U £529.00 Quantity Add to Order

Description

Plasmid-Safe™ ATP-Dependent DNase selectively removes contaminating bacterial chromosomal DNA from plasmid, cosmid, fosmid, and BAC clones or vector preparations. Such preparations are frequently contaminated with fragments of bacterial genomic DNA generated during alkaline lysis. Other purification options, such as spin-columns or even CsCl centrifugation, do not effectively remove these contaminants and require further purification steps. Contaminating DNA fragments left behind by these methods ultimately can become ligated into a cloning vector, resulting in false positives and high backgrounds, or erroneous sequence data.

Plasmid-Safe ATP-Dependent DNase digests linear dsDNA to deoxynucleotides at slightly alkaline pH and, with lower efficiency, closed-circular and linear ssDNA. The enzyme has no activity on nicked or closed-circular dsDNA or supercoiled DNA. Therefore, Plasmid-Safe DNase is ideal as the final purification step for plasmid, cosmid, fosmid, and BAC vector and clone preparations

Figure 1. Plasmid-Safe™ ATP-Dependent DNase removes contaminating genomic DNA from plasmid preps
Figure 1. Plasmid-Safe™ ATP-Dependent DNase removes contaminating genomic DNA from plasmid preps. Lane 1, 3 µg of Sma I-digested bacterial chromosomal DNA; lane 2, 500 ng of uncut plasmid DNA; lane 3, mixture of 3 µg of digested bacterial chromosomal DNA and 500 ng of uncut plasmid before Plasmid-Safe DNase treatment; lane 4, mixture of chromosomal DNA and plasmid DNA after Plasmid-Safe DNase treatment (incubation with Plasmid-Safe DNase for 30 minutes at 37°C); lane M, Kilobase ladder

 Unit Definition

One unit converts 1 nmole of deoxynucleotides in linear T7 DNA into an acid-soluble form in 30 minutes at 37°C using the prescribed assay conditions. Three units will digest 1µg of DNA in 30 minutes at 37°C.

Storage Buffer

50% glycerol containing 50mM Tris-HCl, pH 7.5, 0.1 M NaCl, 0.1mM EDTA, 1mM DTT and 0.1% Triton® X-100.

Plasmid-Safe 10X Reaction Buffer

330 mM Tris-acetate, pH 7.8, 660mM potassium acetate, 100mM magnesium acetate, and 5.0mM DTT. ATP must be added to a final concentration of 1mM in the 1X Buffer.

Quality Control

Plasmid-Safe DNase is free of detectable RNase and double-stranded, DNA-specific endonuclease activities.

Plasmid-Safe Protocol Outline

  1. Isolate DNA from bacteria using standard mini- or maxi-prep protocols
  2. Resuspend the pelleted DNA in 1X Plasmid-Safe Reaction Buffer with 1mM ATP.
  3. Add Plasmid-Safe DNase.
  4. Incubate at 37°C: 15 minutes for mini-prep DNA or 2 hours for DNA from a 500-ml prep.
  5. Inactivate Plasmid-Safe DNase by incubation at 70°C for 30 minutes.
Figure 2 Elimination of linear DNA resulting in white colonies
Figure 2. Elimination of linear DNA resulting in white colonies. Three micrograms of EcoR I-digested bacterial genomic DNA were added to
2 µg of a supercoiled
lacZ-containing plasmid vector. Half of the DNA mixture was treated with Plasmid-Safe DNase; the other half was not treated and served as the control. After heat inactivation of Plasmid-Safe DNase, the DNA was digested with EcoR I, ligated overnight with T4 DNA Ligase (EPICENTRE), and transformed into competent cells. The transformants were plated on IPTG/X-gal-containing medium. Only 1-3% of the colonies transformed by the Plasmid-Safe DNase-treated DNA were white, while greater than 50% of the colonies transformed by the control DNA sample (untreated) were white. Use of Plasmid-Safe DNase resulted in elimination of almost
all of the linear DNA.

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

Protocols

Protocols for: Plasmid-Safe™ ATP-Dependent DNase

Due to the constant updating of the protocols by the manufacturer we have provided a direct link to Epicentre’s product page, where the latest protocol is available.

Please note this will open a new page or window on your computer.

Plasmid-Safe™ Protocol

(catalogue number E3101K / E3105K / E3110K)

Please note: all protocols off site are the responsibility of the products supplier

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

References

References

  1. Sambrook, J. et al. (1989) in: Molecular Cloning: A Laboratory Manual (2nd ed.), Cold Spring Harbor Laboratory Press, New York.
  2. Vandeyar, M.A. (1988) Gene 65, 129.
  3. Luckow, B. et al. (1987) Nucleic Acids Res. 15, 417.
  4. Richardson, C.C. et al. (1964) J. Biol. Chem. 239, 251.
  5. Weiss, B. (1976) J. Biol. Chem. 251, 1896.
  6. Rogers, S.G. and Weiss, B. (1980) Meth. Enzymol. 65, 201.
  7. Guo, L.H. and Wu, R. (1982) Nucleic Acids Res. 10, 2065
  8. Collins, P. L., et al. (2010) Distal Regions of the Human IFNG Locus Direct Cell Type-Specific Expression. J Immunol 185 , 1492-1501.
  9. Edwards, J. R., et al. (2010) Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns. Genome Res 20 , 972-980.
  10. McDougal, L. K., et al. (2010) Emergence of Resistance among USA300 Methicillin-Resistant Staphylococcus aureus Isolates Causing Invasive Disease in the United States. Antimicrob Agents Chemother  , AAC.00351-10.
  11. Parsley, L. C., et al. (2010) Identification of diverse antimicrobial resistance determinants encoded on bacterial, plasmid, or viral metagenomes from an activated sludge microbial assemblage. Appl Envir Microbiol  , AEM.03080-09.
  12. Parsley, L. C., et al. (2010) Identification of Diverse Antimicrobial Resistance Determinants Carried on Bacterial, Plasmid, or Viral Metagenomes from an Activated Sludge Microbial Assemblage. Appl Envir Microbiol 76 , 3753-3757.
  13. Pollicino, T., et al. (2010) HEPATITIS B VIRUS REPLICATIVE AND TRANSCRIPTIONAL ACTIVITIES IN HEPATITIS DELTA VIRUS CO-INFECTED PATIENTS. J Virol , JVI.01609-10.
  14. Sletvold, H., et al. (2010) Tn1546 is part of a larger plasmid-encoded genetic unit horizontally disseminated among clonal Enterococcus faecium lineages. J Antimicrob Chemother , dkq219.
  15. Yuen, M.-F., et al. (2010) Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population. Gut 59 , 1389-1393.
  16. Belloni, L., et al. (2009) Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. PNAS 106 , 19975-19979.
  17. Chung, Y.-L. & Tsai, T.-Y. (2009) Promyelocytic Leukemia Nuclear Bodies Link the DNA Damage Repair Pathway with Hepatitis B Virus Replication: Implications for Hepatitis B Virus Exacerbation during Chemotherapy and Radiotherapy. Mol Cancer Res 7 , 1672-1685.
  18. Schnepp, B. C., et al. (2009) Infectious Molecular Clones of Adeno-Associated Virus Isolated Directly from Human Tissues. J Virol 83 , 1456-1464.
  19. Smyth, D. S. & Robinson, D. A. (2009) Integrative and Sequence Characteristics of a Novel Genetic Element, ICE6013, in Staphylococcus aureus. J Bacteriol 191 , 5964-5975.
  20. Penaud-Budloo, M., et al. (2008) Adeno-Associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle. J Virol 82 , 7875-7885.
  21. Heipertz, R. A., Jr., et al. (2007) In Vitro Study of the Effects of Precore and Lamivudine-Resistant Mutations on Hepatitis B Virus Replication. J Virol 81 , 3068-3076.
  22. Lartigue, C., et al. (2007) Genome Transplantation in Bacteria: Changing One Species to Another. Science 317 , 632-638.
  23. Moritz, E. M. & Hergenrother, P. J. (2007) Toxin-antitoxin systems are ubiquitous and plasmid-encoded in vancomycin-resistant enterococci. PNAS 104 , 311-316.
  24. O'Neill, A. J., et al. (2007) Characterization of the Epidemic European Fusidic Acid-Resistant Impetigo Clone of Staphylococcus aureus. J Clin Microbiol 45 , 1505-1510.
  25. Benderoth, M., et al. (2006) Positive selection driving diversification in plant secondary metabolism. PNAS 103 , 9118-9123.
  26. Wang, C., et al. (2006) Isolation of Poly-3-Hydroxybutyrate Metabolism Genes from Complex Microbial Communities by Phenotypic Complementation of Bacterial Mutants. Appl Envir Microbiol 72 , 384-391.
  27. Yanai, K., et al. (2006) Amplification of the entire kanamycin biosynthetic gene cluster during empirical strain improvement of Streptomyces kanamyceticus. PNAS 103 , 9661-9666.
  28. Jeon, B.-C., et al. (2005) Investigation of a Nosocomial Outbreak of Imipenem-Resistant Acinetobacter baumannii Producing the OXA-23 {beta}-Lactamase in Korea. J Clin Microbiol 43 , 2241-2245.
  29. Schnepp, B. C., et al. (2005) Characterization of Adeno-Associated Virus Genomes Isolated from Human Tissues. J Virol 79 , 14793-14803.
  30. Buck, C. B., et al. (2004) Efficient Intracellular Assembly of Papillomaviral Vectors. J Virol 78 , 751-757.
  31. Lei, X., et al. (2004) Measurement of DNA mismatch repair activity in live cells. Nucleic Acids Res 32 , e100-.
  32. Poly, F., et al. (2004) Identification of Campylobacter jejuni ATCC 43431-Specific Genes by Whole Microbial Genome Comparisons. J Bacteriol 186 , 4781-4795.
  33. Abdelhamed, A. M., et al. (2003) Comparison of Anti-Hepatitis B Virus Activities of Lamivudine and Clevudine by a Quantitative Assay. Antimicrob Agents Chemother 47 , 324-336.
  34. Liles, M. R., et al. (2003) A Census of rRNA Genes and Linked Genomic Sequences within a Soil Metagenomic Library. Appl Envir Microbiol 69 , 2684-2691.
  35. Mason, P. A., et al. (2003) Mismatch repair activity in mammalian mitochondria. Nucleic Acids Res 31 , 1052-1058.
  36. Schnepp, B. C., et al. (2003) Genetic Fate of Recombinant Adeno-Associated Virus Vector Genomes in Muscle. J Virol 77 , 3495-3504.
  37. Abdelhamed, A. M., et al. (2002) Rebound of Hepatitis B Virus Replication in HepG2 Cells after Cessation of Antiviral Treatment. J Virol 76 , 8148-8160.
  38. Apte, S. & Gardner, J. P. A. (2002) Gene order for a segment of the mitochondrial genome of the greenshell mussel, Perna canaliculus (Bivalvia: Mytilidae). J Mollus Stud 68 , 283-286.
  39. Hofreuter, D. & Haas, R. (2002) Characterization of Two Cryptic Helicobacter pylori Plasmids: a Putative Source for Horizontal Gene Transfer and Gene Shuffling. J Bacteriol 184 , 2755-2766.
  40. Morishige, D. T., et al. (2002) Targeted Analysis of Orthologous Phytochrome A Regions of the Sorghum, Maize, and Rice Genomes using Comparative Gene-Island Sequencing. Plant Physiology 130 , 1614-1625.
  41. Ren, S. & Nassal, M. (2001) Hepatitis B Virus (HBV) Virion and Covalently Closed Circular DNA Formation in Primary Tupaia Hepatocytes and Human Hepatoma Cell Lines upon HBV Genome Transduction with Replication-Defective Adenovirus Vectors. J Virol 75 , 1104-1116.
  42. Almazan, F., et al. (2000) From the Cover: Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. PNAS 97 , 5516-5521.
  43. Millar, J. K., et al. (2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9 , 1415-1423.
  44. Delaney, W. E. I. V., et al. (1999) Use of the Hepatitis B Virus Recombinant Baculovirus-HepG2 System to Study the Effects of (-)-beta -2',3'-Dideoxy-3'-Thiacytidine on Replication of Hepatitis B Virus and Accumulation of Covalently Closed Circular DNA. Antimicrob Agents Chemother 43 , 2017-2026.
  45. Somerville, J. E., Jr., et al. (1999) Escherichia coli msbB Gene as a Virulence Factor and a Therapeutic Target. Infect Immun 67 , 6583-6590.
  46. Baynton, K., et al. (1998) Analysis of Damage Tolerance Pathways in Saccharomyces cerevisiae: a Requirement for Rev3 DNA Polymerase in Translesion Synthesis. Mol Cell Biol 18 , 960-966.

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

Applications & Benefits

Applications 

  • Removal of contaminating bacterial chromosomal DNA in plasmid, cosmid, and BAC preparations
  • Treatment of RNA to remove genomic DNA prior to RT-PCR 

Benefits

  • Minimizes the possibility of cloning or sequencing contaminating chromosomal DNA from plasmid, cosmid, fosmid, or BAC preparations.
  • Fast and easy protocol with minimal handling time.
  • Complete protocols provided for using Plasmid-Safe DNase with miniprep, midiprep, and maxiprep plasmid, cosmid, fosmid, and BAC DNA purifications.




If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

Related products

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200